HVH-2930 - CAS 3034605-72-3

HVH-2930 is an inhibitor of Heat Shock Protein 90 (HSP90) . It suppresses the cell viability of BT474 (Trastuzumab sensitive) and JIMT-1 (Trastuzumab resistant) by downregulating HSP90 client proteins such as HER2, p-HER2, AKT, p-AKT, cyclin D1, and survivin, with IC50 values of 6.86 μM and 4.42 μM, respectively. Additionally, HVH-2930 demonstrates antitumor efficacy in a mouse model and exhibits favorable pharmacokinetic properties in vivo.

Survivin, EGFR, HSP, Akt

PI3K/Akt/mTOR signaling, JAK/STAT signaling, Cytoskeletal Signaling, Tyrosine Kinase/Adaptors, Angiogenesis, Apoptosis, Metabolism

3034605-72-3

C29H36N4O3

488.62

O=C(NC=1C=CC=2C(=NN(C2C1)CCC3CCN(C)CC3)C)C4=CC=C5OC(C=CC5=C4OC)(C)C

-20°C

Ice Packs

Small Compound